CTOs on the Move

Mass Medical Svc

www.massmed.com

 
Mass Medical Svc is a Arlington, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.massmed.com
  • 792 Massachusetts Ave
    Arlington, MA USA 02476
  • Phone: 781.648.4041

Executives

Name Title Contact Details

Similar Companies

Perfect Health

Perfect Health, an independent privately held company based in Cambridge, MA, is a full service primary care practice that sees seniors in their own homes.

Wisdo Health

Wisdo is an award-winning social health and clinical referral platform that addresses the adverse consequences of social isolation and loneliness on the mental and physical health of 124 million Americans. Research shows that Wisdo results in $1,900+ in annual medical cost savings, a 37% reduction in depression, a 34% increase in the number of healthy days experienced by our members, and an 80% retention rate on month 12. More than 1 million adults have joined the Wisdo community, where they realized measurable improvements in their health through community-driven social support, professionally moderated group sessions, and when appropriate clinical referrals based on predictive analytics.

Pure Power Athletics d/b/a Makkar Athletics Group

Pure Power Athletics, Inc. d/b/a Makkar Athletics Group is a Oakville, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kymera Therapeutics

Kymera is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. Kymera’s proprietary targeted protein degradation platform, called Pegasus, enables us to discover highly selective small molecule protein degraders with activity against disease-causing proteins throughout the body. We believe that our small molecule protein degraders have significant advantages over existing therapies and allow us to address a large portion of the human genome that was previously intractable with traditional modalities. Kymera focuses on biological pathways that have been clinically validated but where key biological nodes/proteins have not been drugged or have been inadequately drugged. To date, we have utilized our Pegasus platform to design novel protein degraders focused in the areas of immunology-inflammation and oncology, and continue to apply our platform’s capabilities to additional therapeutic areas.

ImprimisRx

ImprimisRx® is a pharmaceutical company dedicated to delivering high-quality and innovative medicines to physicians and patients at affordable prices. We are pioneering a new commercial pathway in the pharmaceutical industry, using compounding pharmacies for the formulation and distribution of high-quality formulations that are supported by the clinical experience of physicians and their patients. We offer proprietary compounded ophthalmic formulations. All of our innovative drug formulations are born from the clinical experience of physicians and pharmacist formulators. We are focused on people, and believe our unique business model provides us with the opportunity to address unmet patient needs while delivering high quality and affordable medical solutions to physicians and patients.